Global Renal Function Test Market

Renal Function Test Comprehensive Study by Type (Disposables, Reagents, Dipsticks, Other Products), Application (Hospitals, Clinics, Diagnostic Laboratories, Others), Parameters (Serum Urea (15-45 mg/dL), Serum Creatinine (0.6 – 1.2 mg/dL), Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL), Total protein (6.4-8.1 g/dL), Serum albumin (3.2-4.6 g/dL), Serum electrolytes (Calcium (8.8-10.2 mg/dL))), Test (Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests), Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test), Other tests (Imaging tests)) Players and Region - Global Market Outlook to 2026

Renal Function Test Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Estimation of renal function requires to be precise. Renal Function Tests are performed to evaluate kidney (Renal) functional capacity, diagnose renal impairment, assess the severity and progression of renal impairment along with effectiveness of treatment. Renal Assessment uses either the Blood or Urine and is broadly classifies under two types Glomerular Function & Tubular Function.This growth is primarily driven by Prevalence of Renal Diseases., Medical Industry Highly in demand. and Safe and Secure Approach..

Globally, a noticeable market trend is evident Technical Progress in Medical Industry. . Major Players, such as Abbott Laboratories (United States), Danaher Corporation (United States), F. Hoffmann-La Roche (Switzerland), Sysmex Corporation (Japan), Nova Biomedical Corporation (United States), Siemens Healthineers (Germany), Randox Laboratores (United Kingdom), Quest Diagnostics (United States), Acon Laboratories (United States), Nova Biomedical (United States) and Laboratory Corporation of America Holdings (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 10th September, 2020 – LabCorp acquired Franciscan Missionaries of Our Lady’s clinical ambulatory lab segment. and On 2nd August, 2020 - Siemens Healthineers to acquire Varian to Improve its Cancer Treatment Capabilities, thereby Improving other related Functions. The Deal is Valued to be USD 16.4 Billion.

Market Drivers
  • Prevalence of Renal Diseases.
  • Medical Industry Highly in demand.
  • Safe and Secure Approach.

Market Trend
  • Technical Progress in Medical Industry.
  • Degrees such as Nursing have become Significantly Popular

Restraints
  • Lack of Trained Professionals

Opportunities
Highly advanced Medical Procedures can be Performed with Ease. and Growing reach across Emerging Economies
Challenges
Fierce competitive pressure

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Renal Function Test Study Sheds Light on
— The Renal Function Test Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Renal Function Test industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Renal Function Test industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Disposables
  • Reagents
  • Dipsticks
  • Other Products
By Application
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others
By Parameters
  • Serum Urea (15-45 mg/dL)
  • Serum Creatinine (0.6 – 1.2 mg/dL)
  • Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL)
  • Total protein (6.4-8.1 g/dL)
  • Serum albumin (3.2-4.6 g/dL)
  • Serum electrolytes (Calcium (8.8-10.2 mg/dL))

By Test
  • Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests)
  • Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test)
  • Other tests (Imaging tests)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Renal Diseases.
      • 3.2.2. Medical Industry Highly in demand.
      • 3.2.3. Safe and Secure Approach.
    • 3.3. Market Challenges
      • 3.3.1. Fierce competitive pressure
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry.
      • 3.4.2. Degrees such as Nursing have become Significantly Popular
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Renal Function Test, by Type, Application, Parameters, Test and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Renal Function Test (Value)
      • 5.2.1. Global Renal Function Test by: Type (Value)
        • 5.2.1.1. Disposables
        • 5.2.1.2. Reagents
        • 5.2.1.3. Dipsticks
        • 5.2.1.4. Other Products
      • 5.2.2. Global Renal Function Test by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Laboratories
        • 5.2.2.4. Others
      • 5.2.3. Global Renal Function Test by: Parameters (Value)
        • 5.2.3.1. Serum Urea (15-45 mg/dL)
        • 5.2.3.2. Serum Creatinine (0.6 – 1.2 mg/dL)
        • 5.2.3.3. Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL)
        • 5.2.3.4. Total protein (6.4-8.1 g/dL)
        • 5.2.3.5. Serum albumin (3.2-4.6 g/dL)
        • 5.2.3.6. Serum electrolytes (Calcium (8.8-10.2 mg/dL))
      • 5.2.4. Global Renal Function Test by: Test (Value)
        • 5.2.4.1. Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests)
        • 5.2.4.2. Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test)
        • 5.2.4.3. Other tests (Imaging tests)
      • 5.2.5. Global Renal Function Test Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Renal Function Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sysmex Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nova Biomedical Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Siemens Healthineers (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Randox Laboratores (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quest Diagnostics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Acon Laboratories (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nova Biomedical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Laboratory Corporation of America Holdings (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Renal Function Test Sale, by Type, Application, Parameters, Test and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Renal Function Test (Value)
      • 7.2.1. Global Renal Function Test by: Type (Value)
        • 7.2.1.1. Disposables
        • 7.2.1.2. Reagents
        • 7.2.1.3. Dipsticks
        • 7.2.1.4. Other Products
      • 7.2.2. Global Renal Function Test by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Laboratories
        • 7.2.2.4. Others
      • 7.2.3. Global Renal Function Test by: Parameters (Value)
        • 7.2.3.1. Serum Urea (15-45 mg/dL)
        • 7.2.3.2. Serum Creatinine (0.6 – 1.2 mg/dL)
        • 7.2.3.3. Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL)
        • 7.2.3.4. Total protein (6.4-8.1 g/dL)
        • 7.2.3.5. Serum albumin (3.2-4.6 g/dL)
        • 7.2.3.6. Serum electrolytes (Calcium (8.8-10.2 mg/dL))
      • 7.2.4. Global Renal Function Test by: Test (Value)
        • 7.2.4.1. Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests)
        • 7.2.4.2. Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test)
        • 7.2.4.3. Other tests (Imaging tests)
      • 7.2.5. Global Renal Function Test Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Renal Function Test: by Type(USD Million)
  • Table 2. Renal Function Test Disposables , by Region USD Million (2015-2020)
  • Table 3. Renal Function Test Reagents , by Region USD Million (2015-2020)
  • Table 4. Renal Function Test Dipsticks , by Region USD Million (2015-2020)
  • Table 5. Renal Function Test Other Products , by Region USD Million (2015-2020)
  • Table 6. Renal Function Test: by Application(USD Million)
  • Table 7. Renal Function Test Hospitals , by Region USD Million (2015-2020)
  • Table 8. Renal Function Test Clinics , by Region USD Million (2015-2020)
  • Table 9. Renal Function Test Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 10. Renal Function Test Others , by Region USD Million (2015-2020)
  • Table 11. Renal Function Test: by Parameters(USD Million)
  • Table 12. Renal Function Test Serum Urea (15-45 mg/dL) , by Region USD Million (2015-2020)
  • Table 13. Renal Function Test Serum Creatinine (0.6 – 1.2 mg/dL) , by Region USD Million (2015-2020)
  • Table 14. Renal Function Test Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL) , by Region USD Million (2015-2020)
  • Table 15. Renal Function Test Total protein (6.4-8.1 g/dL) , by Region USD Million (2015-2020)
  • Table 16. Renal Function Test Serum albumin (3.2-4.6 g/dL) , by Region USD Million (2015-2020)
  • Table 17. Renal Function Test Serum electrolytes (Calcium (8.8-10.2 mg/dL)) , by Region USD Million (2015-2020)
  • Table 18. Renal Function Test: by Test(USD Million)
  • Table 19. Renal Function Test Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests) , by Region USD Million (2015-2020)
  • Table 20. Renal Function Test Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test) , by Region USD Million (2015-2020)
  • Table 21. Renal Function Test Other tests (Imaging tests) , by Region USD Million (2015-2020)
  • Table 22. South America Renal Function Test, by Country USD Million (2015-2020)
  • Table 23. South America Renal Function Test, by Type USD Million (2015-2020)
  • Table 24. South America Renal Function Test, by Application USD Million (2015-2020)
  • Table 25. South America Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 26. South America Renal Function Test, by Test USD Million (2015-2020)
  • Table 27. Brazil Renal Function Test, by Type USD Million (2015-2020)
  • Table 28. Brazil Renal Function Test, by Application USD Million (2015-2020)
  • Table 29. Brazil Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 30. Brazil Renal Function Test, by Test USD Million (2015-2020)
  • Table 31. Argentina Renal Function Test, by Type USD Million (2015-2020)
  • Table 32. Argentina Renal Function Test, by Application USD Million (2015-2020)
  • Table 33. Argentina Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 34. Argentina Renal Function Test, by Test USD Million (2015-2020)
  • Table 35. Rest of South America Renal Function Test, by Type USD Million (2015-2020)
  • Table 36. Rest of South America Renal Function Test, by Application USD Million (2015-2020)
  • Table 37. Rest of South America Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 38. Rest of South America Renal Function Test, by Test USD Million (2015-2020)
  • Table 39. Asia Pacific Renal Function Test, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Renal Function Test, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Renal Function Test, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 43. Asia Pacific Renal Function Test, by Test USD Million (2015-2020)
  • Table 44. China Renal Function Test, by Type USD Million (2015-2020)
  • Table 45. China Renal Function Test, by Application USD Million (2015-2020)
  • Table 46. China Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 47. China Renal Function Test, by Test USD Million (2015-2020)
  • Table 48. Japan Renal Function Test, by Type USD Million (2015-2020)
  • Table 49. Japan Renal Function Test, by Application USD Million (2015-2020)
  • Table 50. Japan Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 51. Japan Renal Function Test, by Test USD Million (2015-2020)
  • Table 52. India Renal Function Test, by Type USD Million (2015-2020)
  • Table 53. India Renal Function Test, by Application USD Million (2015-2020)
  • Table 54. India Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 55. India Renal Function Test, by Test USD Million (2015-2020)
  • Table 56. South Korea Renal Function Test, by Type USD Million (2015-2020)
  • Table 57. South Korea Renal Function Test, by Application USD Million (2015-2020)
  • Table 58. South Korea Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 59. South Korea Renal Function Test, by Test USD Million (2015-2020)
  • Table 60. Taiwan Renal Function Test, by Type USD Million (2015-2020)
  • Table 61. Taiwan Renal Function Test, by Application USD Million (2015-2020)
  • Table 62. Taiwan Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 63. Taiwan Renal Function Test, by Test USD Million (2015-2020)
  • Table 64. Australia Renal Function Test, by Type USD Million (2015-2020)
  • Table 65. Australia Renal Function Test, by Application USD Million (2015-2020)
  • Table 66. Australia Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 67. Australia Renal Function Test, by Test USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Renal Function Test, by Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Renal Function Test, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Renal Function Test, by Test USD Million (2015-2020)
  • Table 72. Europe Renal Function Test, by Country USD Million (2015-2020)
  • Table 73. Europe Renal Function Test, by Type USD Million (2015-2020)
  • Table 74. Europe Renal Function Test, by Application USD Million (2015-2020)
  • Table 75. Europe Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 76. Europe Renal Function Test, by Test USD Million (2015-2020)
  • Table 77. Germany Renal Function Test, by Type USD Million (2015-2020)
  • Table 78. Germany Renal Function Test, by Application USD Million (2015-2020)
  • Table 79. Germany Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 80. Germany Renal Function Test, by Test USD Million (2015-2020)
  • Table 81. France Renal Function Test, by Type USD Million (2015-2020)
  • Table 82. France Renal Function Test, by Application USD Million (2015-2020)
  • Table 83. France Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 84. France Renal Function Test, by Test USD Million (2015-2020)
  • Table 85. Italy Renal Function Test, by Type USD Million (2015-2020)
  • Table 86. Italy Renal Function Test, by Application USD Million (2015-2020)
  • Table 87. Italy Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 88. Italy Renal Function Test, by Test USD Million (2015-2020)
  • Table 89. United Kingdom Renal Function Test, by Type USD Million (2015-2020)
  • Table 90. United Kingdom Renal Function Test, by Application USD Million (2015-2020)
  • Table 91. United Kingdom Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 92. United Kingdom Renal Function Test, by Test USD Million (2015-2020)
  • Table 93. Netherlands Renal Function Test, by Type USD Million (2015-2020)
  • Table 94. Netherlands Renal Function Test, by Application USD Million (2015-2020)
  • Table 95. Netherlands Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 96. Netherlands Renal Function Test, by Test USD Million (2015-2020)
  • Table 97. Rest of Europe Renal Function Test, by Type USD Million (2015-2020)
  • Table 98. Rest of Europe Renal Function Test, by Application USD Million (2015-2020)
  • Table 99. Rest of Europe Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 100. Rest of Europe Renal Function Test, by Test USD Million (2015-2020)
  • Table 101. MEA Renal Function Test, by Country USD Million (2015-2020)
  • Table 102. MEA Renal Function Test, by Type USD Million (2015-2020)
  • Table 103. MEA Renal Function Test, by Application USD Million (2015-2020)
  • Table 104. MEA Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 105. MEA Renal Function Test, by Test USD Million (2015-2020)
  • Table 106. Middle East Renal Function Test, by Type USD Million (2015-2020)
  • Table 107. Middle East Renal Function Test, by Application USD Million (2015-2020)
  • Table 108. Middle East Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 109. Middle East Renal Function Test, by Test USD Million (2015-2020)
  • Table 110. Africa Renal Function Test, by Type USD Million (2015-2020)
  • Table 111. Africa Renal Function Test, by Application USD Million (2015-2020)
  • Table 112. Africa Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 113. Africa Renal Function Test, by Test USD Million (2015-2020)
  • Table 114. North America Renal Function Test, by Country USD Million (2015-2020)
  • Table 115. North America Renal Function Test, by Type USD Million (2015-2020)
  • Table 116. North America Renal Function Test, by Application USD Million (2015-2020)
  • Table 117. North America Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 118. North America Renal Function Test, by Test USD Million (2015-2020)
  • Table 119. United States Renal Function Test, by Type USD Million (2015-2020)
  • Table 120. United States Renal Function Test, by Application USD Million (2015-2020)
  • Table 121. United States Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 122. United States Renal Function Test, by Test USD Million (2015-2020)
  • Table 123. Canada Renal Function Test, by Type USD Million (2015-2020)
  • Table 124. Canada Renal Function Test, by Application USD Million (2015-2020)
  • Table 125. Canada Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 126. Canada Renal Function Test, by Test USD Million (2015-2020)
  • Table 127. Mexico Renal Function Test, by Type USD Million (2015-2020)
  • Table 128. Mexico Renal Function Test, by Application USD Million (2015-2020)
  • Table 129. Mexico Renal Function Test, by Parameters USD Million (2015-2020)
  • Table 130. Mexico Renal Function Test, by Test USD Million (2015-2020)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Renal Function Test: by Type(USD Million)
  • Table 143. Renal Function Test Disposables , by Region USD Million (2021-2026)
  • Table 144. Renal Function Test Reagents , by Region USD Million (2021-2026)
  • Table 145. Renal Function Test Dipsticks , by Region USD Million (2021-2026)
  • Table 146. Renal Function Test Other Products , by Region USD Million (2021-2026)
  • Table 147. Renal Function Test: by Application(USD Million)
  • Table 148. Renal Function Test Hospitals , by Region USD Million (2021-2026)
  • Table 149. Renal Function Test Clinics , by Region USD Million (2021-2026)
  • Table 150. Renal Function Test Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 151. Renal Function Test Others , by Region USD Million (2021-2026)
  • Table 152. Renal Function Test: by Parameters(USD Million)
  • Table 153. Renal Function Test Serum Urea (15-45 mg/dL) , by Region USD Million (2021-2026)
  • Table 154. Renal Function Test Serum Creatinine (0.6 – 1.2 mg/dL) , by Region USD Million (2021-2026)
  • Table 155. Renal Function Test Serum Uric acid (Males 3.5-7.2 mg/dl, Females 2.6-6 mg/dL) , by Region USD Million (2021-2026)
  • Table 156. Renal Function Test Total protein (6.4-8.1 g/dL) , by Region USD Million (2021-2026)
  • Table 157. Renal Function Test Serum albumin (3.2-4.6 g/dL) , by Region USD Million (2021-2026)
  • Table 158. Renal Function Test Serum electrolytes (Calcium (8.8-10.2 mg/dL)) , by Region USD Million (2021-2026)
  • Table 159. Renal Function Test: by Test(USD Million)
  • Table 160. Renal Function Test Test for Glomerular Function (Serum Urea, Serum Creatinine, Clearance tests) , by Region USD Million (2021-2026)
  • Table 161. Renal Function Test Tests for Tubular Function (Blood Tests, Urine, Dilution test, Para amino hippuric acid, Clearance test, Acidification test) , by Region USD Million (2021-2026)
  • Table 162. Renal Function Test Other tests (Imaging tests) , by Region USD Million (2021-2026)
  • Table 163. South America Renal Function Test, by Country USD Million (2021-2026)
  • Table 164. South America Renal Function Test, by Type USD Million (2021-2026)
  • Table 165. South America Renal Function Test, by Application USD Million (2021-2026)
  • Table 166. South America Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 167. South America Renal Function Test, by Test USD Million (2021-2026)
  • Table 168. Brazil Renal Function Test, by Type USD Million (2021-2026)
  • Table 169. Brazil Renal Function Test, by Application USD Million (2021-2026)
  • Table 170. Brazil Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 171. Brazil Renal Function Test, by Test USD Million (2021-2026)
  • Table 172. Argentina Renal Function Test, by Type USD Million (2021-2026)
  • Table 173. Argentina Renal Function Test, by Application USD Million (2021-2026)
  • Table 174. Argentina Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 175. Argentina Renal Function Test, by Test USD Million (2021-2026)
  • Table 176. Rest of South America Renal Function Test, by Type USD Million (2021-2026)
  • Table 177. Rest of South America Renal Function Test, by Application USD Million (2021-2026)
  • Table 178. Rest of South America Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 179. Rest of South America Renal Function Test, by Test USD Million (2021-2026)
  • Table 180. Asia Pacific Renal Function Test, by Country USD Million (2021-2026)
  • Table 181. Asia Pacific Renal Function Test, by Type USD Million (2021-2026)
  • Table 182. Asia Pacific Renal Function Test, by Application USD Million (2021-2026)
  • Table 183. Asia Pacific Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 184. Asia Pacific Renal Function Test, by Test USD Million (2021-2026)
  • Table 185. China Renal Function Test, by Type USD Million (2021-2026)
  • Table 186. China Renal Function Test, by Application USD Million (2021-2026)
  • Table 187. China Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 188. China Renal Function Test, by Test USD Million (2021-2026)
  • Table 189. Japan Renal Function Test, by Type USD Million (2021-2026)
  • Table 190. Japan Renal Function Test, by Application USD Million (2021-2026)
  • Table 191. Japan Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 192. Japan Renal Function Test, by Test USD Million (2021-2026)
  • Table 193. India Renal Function Test, by Type USD Million (2021-2026)
  • Table 194. India Renal Function Test, by Application USD Million (2021-2026)
  • Table 195. India Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 196. India Renal Function Test, by Test USD Million (2021-2026)
  • Table 197. South Korea Renal Function Test, by Type USD Million (2021-2026)
  • Table 198. South Korea Renal Function Test, by Application USD Million (2021-2026)
  • Table 199. South Korea Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 200. South Korea Renal Function Test, by Test USD Million (2021-2026)
  • Table 201. Taiwan Renal Function Test, by Type USD Million (2021-2026)
  • Table 202. Taiwan Renal Function Test, by Application USD Million (2021-2026)
  • Table 203. Taiwan Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 204. Taiwan Renal Function Test, by Test USD Million (2021-2026)
  • Table 205. Australia Renal Function Test, by Type USD Million (2021-2026)
  • Table 206. Australia Renal Function Test, by Application USD Million (2021-2026)
  • Table 207. Australia Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 208. Australia Renal Function Test, by Test USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Renal Function Test, by Type USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific Renal Function Test, by Application USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Renal Function Test, by Test USD Million (2021-2026)
  • Table 213. Europe Renal Function Test, by Country USD Million (2021-2026)
  • Table 214. Europe Renal Function Test, by Type USD Million (2021-2026)
  • Table 215. Europe Renal Function Test, by Application USD Million (2021-2026)
  • Table 216. Europe Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 217. Europe Renal Function Test, by Test USD Million (2021-2026)
  • Table 218. Germany Renal Function Test, by Type USD Million (2021-2026)
  • Table 219. Germany Renal Function Test, by Application USD Million (2021-2026)
  • Table 220. Germany Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 221. Germany Renal Function Test, by Test USD Million (2021-2026)
  • Table 222. France Renal Function Test, by Type USD Million (2021-2026)
  • Table 223. France Renal Function Test, by Application USD Million (2021-2026)
  • Table 224. France Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 225. France Renal Function Test, by Test USD Million (2021-2026)
  • Table 226. Italy Renal Function Test, by Type USD Million (2021-2026)
  • Table 227. Italy Renal Function Test, by Application USD Million (2021-2026)
  • Table 228. Italy Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 229. Italy Renal Function Test, by Test USD Million (2021-2026)
  • Table 230. United Kingdom Renal Function Test, by Type USD Million (2021-2026)
  • Table 231. United Kingdom Renal Function Test, by Application USD Million (2021-2026)
  • Table 232. United Kingdom Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 233. United Kingdom Renal Function Test, by Test USD Million (2021-2026)
  • Table 234. Netherlands Renal Function Test, by Type USD Million (2021-2026)
  • Table 235. Netherlands Renal Function Test, by Application USD Million (2021-2026)
  • Table 236. Netherlands Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 237. Netherlands Renal Function Test, by Test USD Million (2021-2026)
  • Table 238. Rest of Europe Renal Function Test, by Type USD Million (2021-2026)
  • Table 239. Rest of Europe Renal Function Test, by Application USD Million (2021-2026)
  • Table 240. Rest of Europe Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 241. Rest of Europe Renal Function Test, by Test USD Million (2021-2026)
  • Table 242. MEA Renal Function Test, by Country USD Million (2021-2026)
  • Table 243. MEA Renal Function Test, by Type USD Million (2021-2026)
  • Table 244. MEA Renal Function Test, by Application USD Million (2021-2026)
  • Table 245. MEA Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 246. MEA Renal Function Test, by Test USD Million (2021-2026)
  • Table 247. Middle East Renal Function Test, by Type USD Million (2021-2026)
  • Table 248. Middle East Renal Function Test, by Application USD Million (2021-2026)
  • Table 249. Middle East Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 250. Middle East Renal Function Test, by Test USD Million (2021-2026)
  • Table 251. Africa Renal Function Test, by Type USD Million (2021-2026)
  • Table 252. Africa Renal Function Test, by Application USD Million (2021-2026)
  • Table 253. Africa Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 254. Africa Renal Function Test, by Test USD Million (2021-2026)
  • Table 255. North America Renal Function Test, by Country USD Million (2021-2026)
  • Table 256. North America Renal Function Test, by Type USD Million (2021-2026)
  • Table 257. North America Renal Function Test, by Application USD Million (2021-2026)
  • Table 258. North America Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 259. North America Renal Function Test, by Test USD Million (2021-2026)
  • Table 260. United States Renal Function Test, by Type USD Million (2021-2026)
  • Table 261. United States Renal Function Test, by Application USD Million (2021-2026)
  • Table 262. United States Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 263. United States Renal Function Test, by Test USD Million (2021-2026)
  • Table 264. Canada Renal Function Test, by Type USD Million (2021-2026)
  • Table 265. Canada Renal Function Test, by Application USD Million (2021-2026)
  • Table 266. Canada Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 267. Canada Renal Function Test, by Test USD Million (2021-2026)
  • Table 268. Mexico Renal Function Test, by Type USD Million (2021-2026)
  • Table 269. Mexico Renal Function Test, by Application USD Million (2021-2026)
  • Table 270. Mexico Renal Function Test, by Parameters USD Million (2021-2026)
  • Table 271. Mexico Renal Function Test, by Test USD Million (2021-2026)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Renal Function Test: by Type USD Million (2015-2020)
  • Figure 5. Global Renal Function Test: by Application USD Million (2015-2020)
  • Figure 6. Global Renal Function Test: by Parameters USD Million (2015-2020)
  • Figure 7. Global Renal Function Test: by Test USD Million (2015-2020)
  • Figure 8. South America Renal Function Test Share (%), by Country
  • Figure 9. Asia Pacific Renal Function Test Share (%), by Country
  • Figure 10. Europe Renal Function Test Share (%), by Country
  • Figure 11. MEA Renal Function Test Share (%), by Country
  • Figure 12. North America Renal Function Test Share (%), by Country
  • Figure 13. Global Renal Function Test share by Players 2020 (%)
  • Figure 14. Global Renal Function Test share by Players (Top 3) 2020(%)
  • Figure 15. Global Renal Function Test share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 19. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 21. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2020
  • Figure 23. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Sysmex Corporation (Japan) Revenue: by Geography 2020
  • Figure 25. Nova Biomedical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Nova Biomedical Corporation (United States) Revenue: by Geography 2020
  • Figure 27. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Siemens Healthineers (Germany) Revenue: by Geography 2020
  • Figure 29. Randox Laboratores (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Randox Laboratores (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Quest Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 32. Quest Diagnostics (United States) Revenue: by Geography 2020
  • Figure 33. Acon Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 34. Acon Laboratories (United States) Revenue: by Geography 2020
  • Figure 35. Nova Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 36. Nova Biomedical (United States) Revenue: by Geography 2020
  • Figure 37. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 38. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2020
  • Figure 39. Global Renal Function Test: by Type USD Million (2021-2026)
  • Figure 40. Global Renal Function Test: by Application USD Million (2021-2026)
  • Figure 41. Global Renal Function Test: by Parameters USD Million (2021-2026)
  • Figure 42. Global Renal Function Test: by Test USD Million (2021-2026)
  • Figure 43. South America Renal Function Test Share (%), by Country
  • Figure 44. Asia Pacific Renal Function Test Share (%), by Country
  • Figure 45. Europe Renal Function Test Share (%), by Country
  • Figure 46. MEA Renal Function Test Share (%), by Country
  • Figure 47. North America Renal Function Test Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Danaher Corporation (United States)
  • F. Hoffmann-La Roche (Switzerland)
  • Sysmex Corporation (Japan)
  • Nova Biomedical Corporation (United States)
  • Siemens Healthineers (Germany)
  • Randox Laboratores (United Kingdom)
  • Quest Diagnostics (United States)
  • Acon Laboratories (United States)
  • Nova Biomedical (United States)
  • Laboratory Corporation of America Holdings (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 203 Pages 77 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Renal Function Test Market Quantitative research analysis
Global Renal Function Test Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Renal Function Test Market Report?

Have a Query? Click Here

Other Related Reports

Chronic Diseases Management Comprehensive Study by Application (Ambulatory Care Centers, Hospitals and Physician Groups, Diagnostic Centers, Home Healthcare Agencies and Nursing Homes, Others), Disea...
$ 3450
Salmonella Testing Comprehensive Study by Type (Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scattering), Application (Hospitals, Public Health Labs, Physician Offic...
$ 3350
Facial Aesthetics Comprehensive Study by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion, Hyaluronic acid), Application (Facial Line Correction Treatment, Scar Treatment, Lip ...
$ 3650
Basal Cell Carcinoma Treatment Comprehensive Study by Application (Hospitals, Specialty Clinics, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4), Treatment Type (Surgery {Surgical Excis...
$ 3750
Pulmonary Drug Delivery Systems Comprehensive Study by Type (Metered Dose Inhalers (Manually-Actuated Pressurized Inhaler, Breath-Actuated Pressurized Inhaler), Dry Powder Inhalers (Single-Dose Inhal...
$ 3750
Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessori...
$ 3750